Coming soon…

Coming soon…

480 Opinion 14 Robert-Guroff, M. et al. (1998) Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency vir...

22KB Sizes 5 Downloads 170 Views

480

Opinion

14 Robert-Guroff, M. et al. (1998) Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus. J. Virol. 72, 10275–10280 15 Novembre, F.J. et al. (1997) Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J. Virol. 71, 4086–4091 16 Shibata, R. et al. (1991) Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65, 3514–3520 17 Sakuragi, S. et al. (1992) Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J. Gen. Virol. 73, 2983–2987 18 Kuwata, T. et al. (1995) Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J. Gen. Virol. 76, 2181–2191 19 Haga, T. et al. (1998) A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 liveattenuated vaccines. Microbiol. Immunol. 42, 245–251 20 Hayami, M. and Igarashi, T. (1997) SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. Leukemia 11 (Suppl. 3), 95–97 21 Hayami, M. et al. (1999) Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use. Leukemia 13 (Suppl. 1), S42–S47 22 Igarashi, T. et al. (1997) Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate liveattenuated human AIDS vaccine. J. Gen. Virol. 78, 985–989 23 Igarashi, T. et al. (1998) Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx). Microbiol. Immunol. 42, 71–74 24 Wyand, M.S. et al. (1997) Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat. Med. 3, 32–36 25 Kuwata, T. et al. (1996) Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS 10, 1331–1337 26 Lu, Y. et al. (1996) Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. AIDS Hum. Retroviruses 12, 99–106 27 Cafaro, A. et al. (1999) Control of SHIV-89.6Pinfection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med. 5, 643–650 28 Heeney, J. et al. (1999) HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunol. Lett. 66, 189–195 29 Reimann, K.A. et al. (1996) An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human http://tim.trends.com

TRENDS in Microbiology Vol.9 No.10 October 2001

30

31

32

33

34

35

36

37

38

39

40

41

42

43

immunodeficiency virus in rhesus monkeys. J. Virol. 70, 3198–3206 Luciw, P.A. et al. (1995) Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. U. S. A. 92, 7490–7494 Himathongkham, S. et al. (2000) Simian–human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques. J. Virol. 74, 7851–7860 Chen, Z. et al. (2000) Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pigtailed macaques (Macaca nemestrina). J. Virol. 74, 6501–6510 Joag, S.V. et al. (1996) Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70, 3189–3197 Reimann, K.A. et al. (1996) A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS- like disease after in vivo passage in rhesus monkeys. J. Virol. 70, 6922–6928 Kozyrev, I.L. et al. (2001) Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus. Virology 282, 6–13 Etemad-Moghadam, B. et al. (2001) Membranefusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD4(+) T-cell depletion in macaques infected by a simian–human immunodeficiency virus. J. Virol. 75, 5646–5655 Kestler, H.W.R. et al. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651–662 Lang, S.M. et al. (1993) Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902–912 Voss, G. and Letvin, N.L. (1996) Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys. J. Virol. 70, 7335–7340 Lekutis, C. and Letvin, N.L. (1997) HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. J. Immunol. 159, 2049–2057 CDC (1997) Nonhuman primate spumavirus infections among persons with occupational exposure – United States, 1996. Morb. Mortal. Wkly Rep. 46, 129–131 Khabbaz, R.F. et al. (1992) Simian immunodeficiency virus needlestick accident in a laboratory worker. Lancet 340, 271–273 Khabbaz, R.F. et al. (1994) Brief report: infection of a laboratory worker with simian immunodeficiency virus. New Engl. J. Med. 330, 172–177

44 Ui, M. et al. (1999) Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265, 252–263 45 Ui, M. et al. (1999) Protective immunity of genedeleted SHIVs having an HIV-1 Env against challenge infection with a gene-intact SHIV. J. Med. Primatol. 28, 242–248 46 Iida, T. et al. (1999) Sequential analysis of apoptosis induction in peripheral blood mononuclear cells and lymph nodes in the early phase of pathogenic and nonpathogenic SIVmac infection. AIDS Res. Hum. Retroviruses 15, 721–729 47 Iida, T. et al. (2000) Role of apoptosis induction in both peripheral lymph nodes and thymus in progressive loss of CD4+ cells in SHIV-infected macaques. AIDS Res. Hum. Retroviruses 16, 9–18 48 Ten Haaft, P. et al. (1998) A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian–human immunodeficiency virus-infected macaques. J. Virol. 72, 10281–10285 49 Hirsch, V.M. et al. (1995) Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J. Virol. 69, 955–967 50 Xiao, Y. et al. (2000) Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Virology 269, 268–275 51 Hahn, B.H. et al. (2000) AIDS as a zoonosis: scientific and public health implications. Science 287, 607–614 52 Broussard, S.R. et al. (2001) Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75, 2262–2275 53 Rey-Cuille, M.A. et al. (1998) Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72, 3872–3886

Coming soon...

From the Dec 2001 issue, Trends in Microbiology will be publishing articles on-line ahead of print. Don’t miss out- subscribe today!